These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2163865)

  • 21. Dopamine receptor changes in response to prolonged treatment with L-dopa.
    Groppetti A; Flauto C; Parati E; Vescovi A; Rusconi L; Parenti M
    J Neural Transm Suppl; 1986; 22():33-45. PubMed ID: 2946813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: comparison of injection sites.
    Giambalvo CT; Snodgrass SR
    Brain Res; 1978 Sep; 152(3):555-66. PubMed ID: 308384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of sulpiride on amphetamine-induced behaviour in relation to changes in striatal dopamine release in vivo.
    Sharp T; Zetterström T; Ljungberg T; Ungerstedt U
    Eur J Pharmacol; 1986 Oct; 129(3):411-5. PubMed ID: 3780853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo and in vitro evidence of dopaminergic system down regulation induced by chronic L-DOPA.
    Ponzio F; Cimino M; Achilli G; Lipartiti M; Perego C; Vantini G; Algeri S
    Life Sci; 1984 May; 34(22):2107-16. PubMed ID: 6145075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Sonsalla PK; Manzino L; Heikkila RE
    J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circling behavior in normoxic or hypoxic rats with unilateral 6-OHDA nigrostriatal lesion. Part 1. Effects of apomorphine and L-dopa.
    Saligaut C; Daoust M; Moore N; Boismare F
    Methods Find Exp Clin Pharmacol; 1987 Apr; 9(4):219-24. PubMed ID: 3110513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does acute L-DOPA increase active release of dopamine from dopaminergic neurons?
    Ponzio F; Achilli G; Perego C; Rinaldi G; Algeri S
    Brain Res; 1983 Aug; 273(1):45-51. PubMed ID: 6616231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel electrochemical approach for prolonged measurement of absolute levels of extracellular dopamine in brain slices.
    Burrell MH; Atcherley CW; Heien ML; Lipski J
    ACS Chem Neurosci; 2015 Nov; 6(11):1802-12. PubMed ID: 26322962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term facilitation of amphetamine-induced rotational behavior and striatal dopamine release produced by a single exposure to amphetamine: sex differences.
    Robinson TE; Becker JB; Presty SK
    Brain Res; 1982 Dec; 253(1-2):231-41. PubMed ID: 6891283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sedative effects of apomorphine in an animal model of Huntington's disease.
    Sanberg PR; Lehmann J; Fibiger HC
    Arch Neurol; 1979 Jun; 36(6):349-50. PubMed ID: 156535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inactivation of dopamine D-1 or D-2 receptors differentially inhibits stereotypies induced by dopamine agonists in rats.
    Arnt J; Hyttel J; Meier E
    Eur J Pharmacol; 1988 Oct; 155(1-2):37-47. PubMed ID: 2907491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence that striatal efferents relate to different dopamine receptors.
    Herrera-Marschitz M; Ungerstedt U
    Brain Res; 1984 Dec; 323(2):269-78. PubMed ID: 6525513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behavioural and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat.
    Carter CJ; Pycock CJ
    Brain Res; 1980 Jun; 192(1):163-76. PubMed ID: 7189685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for multiple dopamine receptors involved in the modulation of acetylcholine release in the striatum.
    Hársing LG; Vizi ES
    Pol J Pharmacol Pharm; 1985; 37(3):383-96. PubMed ID: 2866504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.
    Sindhu KM; Banerjee R; Senthilkumar KS; Saravanan KS; Raju BC; Rao JM; Mohanakumar KP
    Pharmacol Biochem Behav; 2006 Jun; 84(2):321-9. PubMed ID: 16820197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
    Parker EM; Cubeddu LX
    J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Action of systemic apomorphine on dopamine cell firing after neostriatal kainic acid lesion.
    Baring MD; Walters JR; Eng N
    Brain Res; 1980 Jan; 181(1):214-8. PubMed ID: 7350957
    [No Abstract]   [Full Text] [Related]  

  • 38. Time course of apomorphine-induced circling behaviour after striatal dopamine receptor denervation.
    Oberlander C; Dumont C; Boissier JR
    Eur J Pharmacol; 1980 Mar; 62(1):107-10. PubMed ID: 7189465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different patterns of rotational behavior in rats after dorsal or ventral striatal lesions with ibotenic acid.
    Kafetzopoulos E; Vlaha V; Konitsiotis S
    Pharmacol Biochem Behav; 1988 Feb; 29(2):403-6. PubMed ID: 3362934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine release in rat striatum after administration of L-dope as studied with in vivo electrochemistry.
    Hefti F; Melamed E
    Brain Res; 1981 Nov; 225(2):333-46. PubMed ID: 7306794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.